JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 56(2022) N 2 p. 166-181; DOI 10.1134/S0026893322020108 Full Text

M.S. Nazarenko1,2*, I.A. Koroleva1, A.A. Zarubin1, A.A. Sleptcov1

miRNA Regulome in Different Atherosclerosis Phenotypes

1Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634050 Russia
2Siberian State Medical University, Tomsk, 634050 Russia

*maria.nazarenko@medgenetics.ru
Received - 2021-07-29; Revised - 2021-08-25; Accepted - 2021-08-26

Dysregulation of microRNA (miRNA) expression is associated with a susceptibility to many diseases, including atherosclerotic lesions of the coronary and carotid arteries and the development of clinical complications such as coronary heart disease, myocardial infarction, chronic cerebral ischemia, ischemic stroke. Recently, more and more studies analyze the miRNA regulome including a network of regulatory elements for the expression of miRNAs themselves and targets under their control. The review summarizes the data from articles concerned miRNA expression and changes in DNA methylation in the miRNA genes in human atherosclerotic arteries, as well as with the analysis of the association between single nucleotide polymorphisms and copy number variations in the miRNA genes with clinical complications of atherosclerosis.

microRNA regulome, expression, DNA methylation, single nucleotide variants, copy number variations, atherosclerosis, ischemic heart disease, myocardial infarction, ischemic stroke



JMB-FOOTER RAS-JOURNALS